BREO ELLIPTA 200-25 MCG INHALR

fluticasone furoate and vilanterol trifenatate
$5.3628per EA

Strength

200; 25 ug/1; ug/1

NDC

00173088214

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204275

On Market Since

4/30/2015

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

-0.3%

1Y

-0.4%

3Y

+3.4%

5Y

+9.6%

All

+43.7%